Literature DB >> 33526850

Predicting quality of life in AMD patients-insights on the new NICE classification and on a bolt-on vision dimension for the EQ-5D.

Ricardo De Sousa Peixoto1, Lazar Krstic2, Sophie C L Hill3, Alexander J E Foss4.   

Abstract

BACKGROUND/AIMS: Health-related quality of life (HRQoL) in age-related macular degeneration (AMD) is difficult to estimate as most generic tools underestimate vision. Our aim was to measure the effect of AMD on generic and visual quality of life and how it relates to handicap. We also aimed to validate the NG82 NICE AMD classification. Finally, we studied if a bolt-on visual domain increased the EQ-5D sensitivity to AMD. PATIENTS AND METHODS: Ninety-six patients with AMD participated in this observational cross-sectional study. Visual (VF-14) and generic questionnaires (EQ-5D) with VIS, and the London handicap scale (LHS) was used to quantify HRQoL and handicap. ANOVA and regression analysis were used to identify significant associations.
RESULTS: Visual dysfunction in AMD has a significant effect in VF-14 (P < 0.001), LHS (p < 0.001), and EQ-5D (p = 0.015). The EQ-5D was less sensitive than the VF-14 and LHS and was not significantly correlated with the VIS bolt-on domain (p = 0.608). On the other hand, VIS was significantly associated with visual acuity (p < 0.001), AMD diagnosis (p = 0.005), VF-14 (p < 0.001), and LHS (p < 0.001). The new AMD classification was a good predictor of visual HRQoL and had an excellent association with visual acuity in the best eye.
CONCLUSION: This article shows that visual impairment is associated with lower HRQoL and with an increased handicap. It also suggests that a visual dimension may increase the EQ-5D sensitivity in AMD. There was a relationship between visual impairment and handicap with the items of the new NICE AMD classification, which supports its use.
© 2021. Crown.

Entities:  

Mesh:

Year:  2021        PMID: 33526850      PMCID: PMC8602239          DOI: 10.1038/s41433-021-01414-3

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  1 in total

1.  Exploring patients' expectations and preferences of glaucoma surgery outcomes to facilitate healthcare delivery and inform future glaucoma research.

Authors:  Bina Bhaskar Kulkarni; Paul Leighton; Anthony J King
Journal:  Br J Ophthalmol       Date:  2019-04-03       Impact factor: 4.638

  1 in total
  4 in total

Review 1.  The Role of Inflammation in Retinal Neurodegeneration and Degenerative Diseases.

Authors:  Geetika Kaur; Nikhlesh K Singh
Journal:  Int J Mol Sci       Date:  2021-12-30       Impact factor: 5.923

2.  Anxiety levels moderate the association between visual acuity and health-related quality of life in chronic eye disease patients.

Authors:  Hugo Senra; Laura Hernandez-Moreno; Natacha Moreno; António Filipe Macedo
Journal:  Sci Rep       Date:  2022-02-10       Impact factor: 4.379

3.  Predictors of problems reported on the EQ-5D-3L dimensions among people with impaired vision in northern Portugal.

Authors:  Antonio Filipe Macedo; Amanda Hellström; Robert Massof; Hanna Tuvesson; Mikael Rask; Pedro Lima Ramos; Jalal Safipour; Ina Marteinsdottir; Evalill Nilsson; Cecilia Fagerström; Kristofer Årestedt
Journal:  Health Qual Life Outcomes       Date:  2022-09-06       Impact factor: 3.077

4.  A Patient Perspective on Quality of Life with wAMD: A Podcast.

Authors:  Jill Adelman; Alexander Foss
Journal:  Ophthalmol Ther       Date:  2022-06-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.